GAMBALE , CARLA Statistiche

GAMBALE , CARLA  

DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA  

Mostra records
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.022 secondi).
Titolo Data di pubblicazione Autore(i) File
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 1-gen-2018 Matrone, Antonio; Latrofa, Francesco; Torregrossa, Liborio; Piaggi, Paolo; Gambale, Carla; Faranda, Alessio; Ricci, Debora; Agate, Laura; Molinaro, Eleonora; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM OUTCOME OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER 1-gen-2020 Matrone, Antonio; Gambale, Carla; Torregrossa, Liborio; Piaggi, Paolo; Bianchi, Francesca; Valerio, Laura; Viola, David; Agate, Laura; Molinaro, Eleonora; Materazzi, Gabriele; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 1-gen-2018 Matrone, Antonio; Gambale, Carla; Torregrossa, Liborio; Bianchi, Francesca; Valerio, Laura; Viola, David; Agate, Laura; Molinaro, Eleonora; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 1-gen-2018 Matrone, A.; Gambale, C.; Torregrossa, L.; Bianchi, F.; Valerio, L.; Viola, D.; Agate, L.; Molinaro, E.; Basolo, F.; Vitti, P.; Elisei, R.
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 1-gen-2021 Matrone, Antonio; Gambale, Carla; Prete, Alessandro; Piaggi, Paolo; Cappagli, Virginia; Bottici, Valeria; Romei, Cristina; Ciampi, Raffaele; Torregrossa, Liborio; De Napoli, Luigi; Molinaro, Eleonora; Materazzi, Gabriele; Basolo, Fulvio; Elisei, Rossella
Management and follow-up of differentiated thyroid cancer not submitted to radioiodine treatment: a systematic review 1-gen-2020 Gambale, Carla; Elisei, Rossella; Matrone, Antonio
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 1-gen-2020 Matrone, Antonio; Ceccarini, Giovanni; Beghini, Marianna; Ferrari, Federica; Gambale, Carla; D'Aqui, Mariaida; Piaggi, Paolo; Torregrossa, Liborio; Molinaro, Eleonora; Basolo, Fulvio; Vitti, Paolo; Santini, Ferruccio; Elisei, Rossella
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 1-gen-2022 Ciampi, Raffaele; Romei, Cristina; Ramone, Teresa; Matrone, Antonio; Prete, Alessandro; Gambale, Carla; Materazzi, Gabriele; De Napoli, Luigi; Torregrossa, Liborio; Basolo, Fulvio; Castagna, Maria Grazia; Brilli, Lucia; Ferretti, Elisabetta; Elisei, Rossella
Predictive Value Of High Sensitive Thyroglobulin Assay (USTG) And Neck Ultrasonography (US) At The Time Of Remnant Ablation On Lt-4 Therapy In Patients With Low And Intermediate Risk Differentiated Thyroid Cancer (DTC) 1-gen-2014 Matrone, A.; Gambale, C.; Molinaro, E.; Agate, L.; Bottici, V.; Biagini, A.; Viola, D.; Vitti, P.; Elisei, R.
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 1-gen-2019 Matrone, Antonio; Gambale, Carla; Torregrossa, Liborio; Valerio, Laura; Agate, Laura; Viola, David; Molinaro, Eleonora; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
Radioiodine remnant ablation (RRA) Impact on the dynamic risk of restratification in the short-term follow-up of patients with differentiated thyroid cancer (DTC). 1-gen-2018 Gambale, Carla; Matrone, Antonio; Torregrossa, Liborio; Valerio, Laura; Giani, Carlotta; Agate, Laura; Molinaro, Eleonora; Bianchi, Francesca; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
Recombinant Human Thyrotropin Stimulation Thyroglobulin (rhTSH-Tg) test can identify false serum tg due to heterophilic antibodies in differentiated thyroid cancer (DTC) patients 1-gen-2013 Matrone, A; Gambale, C; Taddei, D; Nencetti, C; Molinaro, E; Agate, L; Bottici, V; Viola, D; Vitti, P; Elisei, R
Systemic treatment of advanced, metastatic, medullary thyroid carcinoma 1-gen-2021 Matrone, Antonio; Gambale, Carla; Prete, Alessandro; Cappagli, Virginia; Lorusso, Loredana; Bottici, Valeria; Elisei, Rossella
The Thymic Hyperplasia (TH) And Biochemical Persistence Of Disease In Patients With Differentiated Thyroid Carcinoma (DTC) 1-gen-2014 Gambale, Carla; Matrone, Antonio; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Biagini, Agnese; Viola, David; Mazzeo, Salvatore; Bianchi, Francesca; Brozzi, Federica; Vitti, Paolo; Elisei, Rossella
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 1-gen-2020 Matrone, Antonio; Faranda, Alessio; Latrofa, Francesco; Gambale, Carla; Stefani Donati, Delio; Molinaro, Eleonora; Agate, Laura; Viola, David; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Elisei, Rossella
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 1-gen-2021 Matrone, Antonio; Gambale, Carla; Biagini, Margherita; Prete, Alessandro; Vitti, Paolo; Elisei, Rossella